Systemic corticosteroids for management of ‘long-COVID’: an evaluation after 3 months of treatment
Some patients even 4 weeks after Corona Virus Disease 2019 (COVID-19) remain to be symptomatic and are known as “long-COVID”. In the present study we performed the follow up evaluation at 3 months of long-COVID patients, after treatment with systemic steroids. During the study duration, out of the...
Guardado en:
Autores principales: | Nitin Goel, Nitesh Goyal, Ravishankar Nagaraja, Raj Kumar |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
PAGEPress Publications
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/57d1169b973d4e8a8aedc3e9a444b838 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Short-Course of Methylprednisolone Improves Respiratory Functional Parameters After 120 Days in Hospitalized COVID-19 Patients (Metcovid Trial): A Randomized Clinical Trial
por: Camila Miriam Suemi Sato Barros, et al.
Publicado: (2021) -
Effect of COVID-19 on Anti-S Antibody Response in Healthcare Workers Six Months Post-Vaccination
por: Robert Flisiak, et al.
Publicado: (2021) -
Common Laboratory Mice Are Susceptible to Infection with the SARS-CoV-2 Beta Variant
por: Ravi Kant, et al.
Publicado: (2021) -
Detection of Antibodies Against the SARS-CoV-2 Spike Protein and Analysis of the Peripheral Blood Mononuclear Cell Transcriptomic Profile, 15 Years After Recovery From SARS
por: Lili Zhao, et al.
Publicado: (2021) -
Pandemia SARS-CoV-2 y embarazo en el Hospital el Pino: un estudio descriptivo
por: Morales M.,Nereida, et al.
Publicado: (2020)